This report, co-authored by MSD and the NCD Alliance and produced by High Lantern Group, outlines the key takeaways from an official T20 side event on the need for sustainable financing for NCDs held on July 6th, 2023.

Despite the headwinds and ongoing challenges faced by the G20, meaningful progress on NCDs is possible in the coming years. If member governments were to implement the WHO’s NCD best buy recommendations, they could avert an estimated 39 million deaths and generate US $2.7 trillion in economic benefits. Moreover, many of the recommendations outlined in this report are beneficial for all parties, saving policymakers precious time and resources, while also improving outcomes for NCD patients. Most importantly, proper investment and scaling up of NCD prevention initiatives could help turn the tide against this looming threat.

Looking ahead, the G20 has several opportunities to ensure NCDs continue to be discussed at the global level. Beyond the inclusion of NCDs in working group agendas, the G20 can provide leadership at key forthcoming global NCD mile- stones, including the WHO Second NCD Financing Dialogue in 2024 and the UN High-Level Meeting on NCDs in 2025. Furthermore, G20 leaders can build on the leadership the Indian government has shown in this area during its G20 Presidency by ensuring the focus on NCD financing is sustained heading into Brazil’s 2024 G20 Presidency.